Document x5g4NeXj1wDd1XGra1do447zQ

* NORTHERN KENTUCKY OFFICE SUITE 340 1717 DIXIE HIGHWAY COVINGTON, KENTUCKY 41011-4704 606-331-2838 513-381-2838 FAX: 513-381-6613 Robert A. Bilott (513)357-9638 bilott@taftlaw.com TAFT, STETTINIUS & HOLLISTER LLP 425 WALNUT STREET, SUITE 1800 CINCINNATI, OHIO 45202-3957 513-381-2838 FAX: 513-381-0205 www.taftlaw.com April! 1,2003 IbOg CLEVELAND OHIO OFFICE 3500 BP TOWER 200 PUBLIC SQUARE CLEVELAND, OHIO 44114-2302 216-241-2838 FAX: 216-241-3707 COLUMBUS, OHIO OFFICE 21 EAST STATE STREET COLUMBUS. OHIO 43215-4221 614-221-2838 FAX:614-221-2007 FEDERAL EXPRESS Dr. Charles M. Auer Chemical Control Division Office of Prevention, Pesticides and Toxic Substances U.S. Environmental Protection Agency 1201 Constitution Avenue, N.W. Mail Code 7405M Washington, DC 20004 TELECOPY Jennifer Seed U.S. Environmental Protection Agency 410 M Street, S.W. Washington, DC 20460 FEDERAL EXPRESS Christopher Jones, Esq. Director Ohio Environmental Protection Agency 122 South Front Street Columbus, OH 43215 FEDERAL EXPRESS Thomas V. Skinner Regional Administrator U.S. Environmental Protection Agency 77 West Jackson Blvd. Chicago, IL 60604 FEDERAL EXPRESS Oscar Hernandez Director, Risk Assessment Division Office of Prevention, Pesticides and Toxic Substances U.S. Environmental Protection Agency 1201 Constitution Avenue, N.W. Mail Code 7405M Washington, DC 20004 FEDERAL EXPRESS John Wheeler, Ph.D. ATSDR 1825 Century Center Blvd. Atlanta, GA 30345 S ^ ro FEDERAL EXPRESS Donald S. Welsh Regional Administrator "zOs ro c Vr> U.S. Environmental Protection Agency Region III 1650 Arch Street Philadelphia, PA 19103-2029 0-o^r0n -oo -H rn o2om Re: Human Health Threat Arising From Releases Of AFOA/APFO/C-8 In West Virginia And Ohio__________________________ _ in ru 1 April 11,2003 Page 2 Ladies and Gentlemen: As a follow up to our letter of April 4, 2003, regarding the potential health threat to those living near the Washington Works plant of E.I. duPont de Nemours and Company located in Wood County, West Virginia, we have enclosed copies of the following documents relating to the health condition of workers at that DuPont plant where C-8 has been used in manufacturing processes since the early 1950s: 1. DuPont Internal Report, "An Investigation Into The Occurrence Of Leukemia At Washington Works" (April 1989) (EID584220-30); and 2. DuPont Internal Final Report, "A Case-Control Study Of Leukemia At The Washington Works Site" (12/31/91) (EID151953-65). RAB/mdm Enclosures cc: R. Edison Hill, Esq. (w/o ends.) Larry A. Winter, Esq. (w/o ends.) Gerald J. Rapien, Esq. (w/o ends.) Mary Dominiak, (USEPA, OPPT) (for inclusion in AR-226) (w/ ends.) (by telecopy) Jb